Investigation of Ethylene Oxide Genotoxicity Dose–Response to Inform Cancer Risk Assessment
Authors:
Open Access
- 1 June 2026
- journal article
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 67 (5-7) , e70072
Abstract
Ethylene oxide (EtO) is primarily used as an intermediate in the manufacture of chemicals, with a minor use as a sterilant for medical equipment and food products. It is a direct‐acting alkylating agent that reacts with cellular macromolecules, including proteins and DNA. EtO has been shown to induce tumors in rodents and humans. DNA reactivity has been the postulated mode of action (MOA) for its carcinogenicity. The current study has investigated the dose response for EtO‐induced genetic damage to inform the biological plausibility of a dose–response model for cancer risk assessment. Male and female B6C3F1 mice (≥ 10/sex/concentration) were exposed to 0, 0.05, 0.1, 0.5, 1, 50, 100, or 200 ppm EtO by whole‐body inhalation (6 h/day for 28 days, 7 days/week). Mutagenicity was assessed by determining the frequency of mutant Pig‐a phenotype in reticulocytes (RET) and mature red blood cells (RBC) on Day 28. Cytogenetic damage was evaluated by the erythrocyte micronucleus (MN) test in blood samples collected on Days 5 and 28. EtO is a relatively weak genotoxicant with treatment‐related increases in Pig‐a and MN frequencies being seen primarily at 200 ppm. The hockey‐stick shaped dose response for genetic damage may be conservatively interpreted as being no more than a linear response with a single slope. Thus, a cancer risk assessment dose–response model consisting of a single shallow linear slope throughout the exposure range is biologically plausible and consistent if EtO were acting through a mutagenic MoA for its carcinogenicity.Keywords
This publication has 31 references indexed in Scilit:
- Genotoxicity as a toxicologically relevant endpoint to inform risk assessment: A case study with ethylene oxideEnvironmental and Molecular Mutagenesis, 2020
- Understanding the importance of low‐molecular weight (ethylene oxide‐ and propylene oxide‐induced) DNA adducts and mutations in risk assessment: Insights from 15 years of research and collaborative discussionsEnvironmental and Molecular Mutagenesis, 2018
- A physiologically based toxicokinetic model for inhaled ethylene and ethylene oxide in mouse, rat, and humanToxicology Letters, 2018
- Dose and temporal evaluation of ethylene oxide-induced mutagenicity in the lungs of male big blue mice following inhalation exposure to carcinogenic concentrationsEnvironmental and Molecular Mutagenesis, 2017
- Contributions of DNA repair and damage response pathways to the non-linear genotoxic responses of alkylating agentsMutation Research - Reviews in Mutation Research, 2016
- Analysis of in vivo mutation data can inform cancer risk assessmentRegulatory Toxicology and Pharmacology, 2008
- Dose-dependent transitions in mechanisms of toxicity: case studiesToxicology and Applied Pharmacology, 2004
- A Physiologically Based Pharmacokinetic Model for Ethylene Oxide in Mouse, Rat, and HumanToxicology and Applied Pharmacology, 2001
- Statistical model for prediction of retrospective exposure to ethylene oxide in an occupational mortality studyAmerican Journal of Industrial Medicine, 1994
- In vitro reaction of ethylene oxide with DNA and characterization of DNA adductsChemico-Biological Interactions, 1992